Now showing items 1-2 of 2

    • Effects of fertility drugs on cancers other than breast and gynecologic malignancies. 

      Brinton, LA; Moghissi, KS; Scoccia, B; Lamb, E; Trabert, B; Niwa, S; Ruggieri, D; Westhoff, CL (Elsevier, 2015-10)
      Abstract OBJECTIVE: To examine the relationship of ovulation-stimulating drugs to risk of cancers other than breast and gynecologic malignancies. DESIGN: Retrospective cohort study, with additional follow-up since ...
    • Endocrine disruptors and prostate cancer risk 

      Prins, Gail S. (Society for Endocrinology, 2008-06-04)
      There is increasing evidence both from epidemiology studies and animal models that specific endocrine-disrupting compounds may influence the development or progression of prostate cancer. In large part, these effects appear ...